

(ShareCast News) - GW Pharmaceuticals has received 'orphan drug' designation from the US regulator for the company's cannabis-derived treatment for a ...


* Israel focuses attention on cannabis research * U.S. marijuana market growing but research stunted * Investment in Israel expected to double in 2016...




* Epidiolex succeeds in Dravet syndrome clinical trial * Shares surge 125 pct on hopes for $1 billion-plus sales (Adds CEO interview, latest shares,...